Appointment booking for Dr. Michael Cheung, MD is currently not available.Dr. Michael Cheung, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Cheung, MD (he/him) is a Surgeon in Fort Lauderdale, FL with over 15 years of experience. What is your opinion of Dr. Michael Cheung, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 15 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Cheung, MD has received over $28,452 which includes payments from the following companies:
$15,587.28 from Allergan Inc.
$3,125.63 from Stryker Corporation
$2,473.30 from ACell, Inc.
$1,586.22 from Integra LifeSciences Corporation
$883.98 from LifeCell Corporation
$753.09 from Medtronic USA, Inc.
$633.58 from Osiris Therapeutics Inc.
$614.51 from Musculoskeletal Transplant Foundation Inc.
$371.10 from AXOGEN
$314.46 from Mentor Worldwide LLC
$298.61 from Baxter Healthcare
$296.36 from Davol Inc.
$242.53 from Galderma Laboratories, L.P.
$175.74 from KCI USA, Inc
$144.48 from Novadaq Technologies Inc.
$138.69 from Mallinckrodt LLC
$108.18 from Vioptix Inc
$103.59 from AcelRx Pharmaceuticals, Inc.
$96.01 from CooperSurgical, Inc.
$92.59 from Organogenesis Inc.
Payments received by Dr. Michael Cheung, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!